Alta Sciences

APRIL 6, 2024

Strategies for Safe and Timely Shipments blussier Sat, 04/06/2024 - 23:35 HTML Your Samples Are in Good Hands With Us! From regulatory precision to preserving sample integrity, shipments can be challenging.

Packaging 52

Packaging Compliance 52

Drug Patent Watch

APRIL 6, 2024

Annual Drug Patent Expirations for ORACEA Oracea is a drug marketed by Galderma Labs Lp and is included in one NDA. It is available from three suppliers.

Drugs 52

Drugs Marketing 52

KIF1A

APRIL 6, 2024

#ScienceSaturday posts share exciting scientific developments and educational resources with the KAND community. Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. KIF1A-Related Research Genetic Alterations in a Large Population of Italian Patients Affected by Neurodevelopmental Disorders We often talk about genetic disorders in the context of mutations that change a protein̵

DNA 111

DNA Medical Schools Therapies Research 111

Drug Patent Watch

APRIL 6, 2024

This chart shows the drugs with the most patents in Russian Federation.

Pharmaceuticals 95

Pharmaceuticals Drugs 95

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials